Systemic melanoma therapy at the end of life: A single institutional retrospective study in Japan
Main Authors: | Ayumi Yoto, MD, Kanade Shimada, MD, Sumiko Takatsuka, MD, Tatsuya Takenouchi, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-03-01
|
Series: | JAAD International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S266632872200147X |
Similar Items
-
A Dramatic Response to Second-Line Nivolumab and Ipilimumab in BRAF-V600-Mutated Metastatic Melanoma
by: Dahlia Fedele, et al.
Published: (2024-01-01) -
Systemic Therapy of Metastatic Melanoma: On the Road to Cure
by: Julian Steininger, et al.
Published: (2021-03-01) -
Significance of BRAF Kinase Inhibitors for Melanoma Treatment: From Bench to Bedside
by: Taku Fujimura, et al.
Published: (2019-09-01) -
Treatment of Advanced Melanoma: Past, Present and Future
by: Taku Fujimura, et al.
Published: (2020-09-01) -
Clinical research progress in the treatment of BRAF V600 mutation-positive advanced melanoma
by: JIANG Jianyun, YING Hongmei
Published: (2022-05-01)